MedPath

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae

Phase 3
Completed
Conditions
Enterobacteriaceae Infections
Interventions
Drug: Antipseudomonal beta-lactam antibiotic
Drug: De-escalation(short-spectrum antibiotic)
First Posted Date
2016-06-10
Last Posted Date
2020-07-17
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
344
Registration Number
NCT02795949
Locations
🇪🇸

Son Espases Hospital, Palma de Mallorca, Spain

🇪🇸

University Hospital Donostia, San Sebastian, Gipúzcoa, Spain

🇪🇸

University Hospital of Bellvitge, Barcelona, Spain

and more 18 locations

Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
Drug: AA Reduced dose-normal diet (A)
Drug: AA reduced dose-fat diet (B)
Drug: AA normal dose-fasting conditions (C)
First Posted Date
2016-04-07
Last Posted Date
2021-01-11
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
42
Registration Number
NCT02730975
Locations
🇪🇸

Hospital Universitario Virgen del Rocío, Seville, Spain

European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems

Completed
Conditions
Carbapenem Resistant Bacteria Infection
First Posted Date
2016-03-16
Last Posted Date
2021-02-21
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
2515
Registration Number
NCT02709408
Locations
🇦🇱

Spitali i Sanatoriumit Shefqet Ndroqi, Tirana, Albania

🇬🇷

Evangelismos General Hospital of Athens, Athens, Greece

🇬🇷

Iaso General Hospital, Cholargos, Greece

and more 47 locations

Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant

Phase 1
Completed
Conditions
Hematopoietic Stem Cell Transplantation
Interventions
Drug: 1000IU/day of Vitamine D
Drug: 5000IU/day of Vitamine D
First Posted Date
2015-11-10
Last Posted Date
2015-11-10
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
150
Registration Number
NCT02600988
Locations
🇪🇸

Raquel Saldaña Moreno, Jerez de la Frontera, Cádiz, Spain

🇪🇸

David Valcárcel Ferreiras, Barcelona, Spain

🇪🇸

Christelle Ferrà i Coll, Badalona, Barcelona, Spain

and more 4 locations

Metformin Experience on Minimal Hepatic Encephalopathy

Phase 4
Conditions
Hepatic Encephalopathy
Liver Cirrhosis
Interventions
Drug: Placebo
First Posted Date
2015-06-12
Last Posted Date
2015-06-12
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
30
Registration Number
NCT02470546
Locations
🇪🇸

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI), Sevilla, Spain

Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients

First Posted Date
2015-04-03
Last Posted Date
2016-02-03
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
20
Registration Number
NCT02408185
Locations
🇪🇸

Hospital Universitario Virgen del Rocío, Seville, Spain

Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae

Phase 3
Completed
Conditions
Enterobacteriaceae Infections
Bloodstream Infection
Interventions
Other: 7 days course of antibiotic treatment
Other: 14 days course of antibiotic treatment
First Posted Date
2015-03-27
Last Posted Date
2017-03-13
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
238
Registration Number
NCT02400268
Locations
🇪🇸

University Hospital Reina Sofía, Córdoba, Spain

🇪🇸

University Hospital Virgen Macarena, Seville, Spain

🇪🇸

Universitary Hospital Málaga, Málaga, Spain

and more 1 locations

Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer

First Posted Date
2015-02-19
Last Posted Date
2017-03-13
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
30
Registration Number
NCT02365805
Locations
🇪🇸

Hospital Universitario Reina Sofía, Córdoba, Spain

🇪🇸

Hospital Universitario Puerta del Mar, Cádiz, Spain

🇪🇸

Hospital Universitario Juan Ramón Jimenez, Huelva, Spain

and more 4 locations

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Phase 3
Completed
Conditions
Infection Due to ESBL Escherichia Coli
Interventions
First Posted Date
2014-05-20
Last Posted Date
2019-08-06
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
161
Registration Number
NCT02142751
Locations
🇪🇸

Hospital Arnau de Vilanova, Vilanova, Lleida, Spain

🇪🇸

Hospital Royo Villanova, Zaragoza, Spain

🇪🇸

Hospital Universitario 12 de Octubre, Madrid, Spain

and more 19 locations

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

Completed
Conditions
Hepatitis C, Chronic
Interventions
First Posted Date
2013-06-24
Last Posted Date
2014-09-04
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Target Recruit Count
770
Registration Number
NCT01884402
Locations
🇪🇸

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI), Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath